198 related articles for article (PubMed ID: 24007700)
1. Immunogenicity and protective efficacy of heparan sulphate binding proteins of Entamoeba histolytica in a guinea pig model of intestinal amoebiasis.
Kaur U; Khurana S; Saikia UN; Dubey ML
Exp Parasitol; 2013 Nov; 135(3):486-96. PubMed ID: 24007700
[TBL] [Abstract][Full Text] [Related]
2. Protection against murine intestinal amoebiasis induced by oral immunization with the 29 kDa antigen of Entamoeba histolytica and cholera toxin.
Carrero JC; Contreras-Rojas A; Sánchez-Hernández B; Petrosyan P; Bobes RJ; Ortiz-Ortiz L; Laclette JP
Exp Parasitol; 2010 Nov; 126(3):359-65. PubMed ID: 20303954
[TBL] [Abstract][Full Text] [Related]
3. Intestinal amoebiasis: antibody-secreting cells and humoral antibodies.
Ghosh PK; Gupta S; Leon LR; Ghosh R; Ruiz Ordaz BH; Ortiz-Ortiz L
J Diarrhoeal Dis Res; 1998 Mar; 16(1):1-7. PubMed ID: 9775574
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.).
Abd Alla MD; Wolf R; White GL; Kosanke SD; Cary D; Verweij JJ; Zhang MJ; Ravdin JI
Vaccine; 2012 Apr; 30(20):3068-75. PubMed ID: 22406457
[TBL] [Abstract][Full Text] [Related]
5. Role of mucosal secretory immunity in the development of an amebiasis vaccine.
Ravdin JI; Kelsall BL
Am J Trop Med Hyg; 1994; 50(5 Suppl):36-41. PubMed ID: 8203722
[TBL] [Abstract][Full Text] [Related]
6. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica.
Ravdin JI; Shain DC; Kelsall BL
Vaccine; 1993; 11(2):241-6. PubMed ID: 8438621
[TBL] [Abstract][Full Text] [Related]
7. A pcDNA-Ehcpadh vaccine against Entamoeba histolytica elicits a protective Th1-like response in hamster liver.
Martínez MB; Rodríguez MA; García-Rivera G; Sánchez T; Hernández-Pando R; Aguilar D; Orozco E
Vaccine; 2009 Jun; 27(31):4176-86. PubMed ID: 19406180
[TBL] [Abstract][Full Text] [Related]
8. Detection of IgG, IgA, IgM and IgE in antibodies in invasive amoebiasis in endemic areas.
Shetty N; Nagpal S; Rao PV; Schroder H
Arch Invest Med (Mex); 1990; 21 Suppl 1():41-6. PubMed ID: 2136501
[TBL] [Abstract][Full Text] [Related]
9. Host-antibody inductivity of virulent Entamoeba histolytica and non-virulent Entamoeba moshkovskii in a mouse model.
Khomkhum N; Leetachewa S; Pawestri AR; Moonsom S
Parasit Vectors; 2019 Mar; 12(1):101. PubMed ID: 30867040
[TBL] [Abstract][Full Text] [Related]
10. Development of amebicidal cell-mediated immunity in gerbils (Meriones unguiculatus) immunized with the galactose-inhibitable adherence lectin of Entamoeba histolytica.
Schain DC; Salata RA; Ravdin JI
J Parasitol; 1995 Aug; 81(4):563-8. PubMed ID: 7623198
[TBL] [Abstract][Full Text] [Related]
11. CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.
Rojas-López AE; Soldevila G; Meza-Pérez S; Dupont G; Ostoa-Saloma P; Wurbel MA; Ventura-Juárez J; Flores-Romo L; García-Zepeda EA
Immunobiology; 2012 Aug; 217(8):795-807. PubMed ID: 22633147
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of entamoeba histolytica/entamoeba dispar by PCR and their correlation with humoral and cellular immunity in individuals with clinical variants of amoebiasis.
Sánchez-Guillén Mdel C; Pérez-Fuentes R; Salgado-Rosas H; Ruiz-Argüelles A; Ackers J; Shire A; Talamas-Rohana P
Am J Trop Med Hyg; 2002 Jun; 66(6):731-7. PubMed ID: 12224582
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody to the amebic lipophosphoglycan-proteophosphoglycan antigens can prevent disease in human intestinal xenografts infected with Entamoeba histolytica.
Zhang Z; Duchêne M; Stanley SL
Infect Immun; 2002 Oct; 70(10):5873-6. PubMed ID: 12228321
[TBL] [Abstract][Full Text] [Related]
14. An experimental model of ameboma in guinea pig.
Bhatti HS; Bhushnurmath S; Mahajan RC; Ganguly NK; Sehgal R
Exp Parasitol; 1992 May; 74(3):283-9. PubMed ID: 1582480
[TBL] [Abstract][Full Text] [Related]
15. Vaccines for amoebiasis: barriers and opportunities.
Stanley SL
Parasitology; 2006; 133 Suppl():S81-6. PubMed ID: 17274850
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of the recombinant serine rich Entamoeba histolytica protein (SREHP) amebiasis vaccine in the African green monkey.
Stanley SL; Blanchard JL; Johnson N; Foster L; Kunz-Jenkins C; Zhang T; Tian K; Cogswell FB
Vaccine; 1995 Jul; 13(10):947-51. PubMed ID: 7483769
[TBL] [Abstract][Full Text] [Related]
17. The role of the secretory immune response in the infection by Entamoeba histolytica.
Carrero JC; Cervantes-Rebolledo C; Aguilar-Díaz H; Díaz-Gallardo MY; Laclette JP; Morales-Montor J
Parasite Immunol; 2007 Jul; 29(7):331-8. PubMed ID: 17576362
[TBL] [Abstract][Full Text] [Related]
18. The immune response in amoebiasis.
Romia SA; Makhlouf LM; al-Shazly AM; el-Malky SA; Hegazi MM
J Egypt Soc Parasitol; 1988 Jun; 18(1):335-9. PubMed ID: 2897401
[No Abstract] [Full Text] [Related]
19. Obtaining of three recombinant antigens of Entamoeba histolytica and evaluation of their immunogenic ability without adjuvant in a hamster model of immunoprotection.
González-Vázquez MC; Carabarin-Lima A; Baylón-Pacheco L; Talamás-Rohana P; Rosales-Encina JL
Acta Trop; 2012 May; 122(2):169-76. PubMed ID: 22266120
[TBL] [Abstract][Full Text] [Related]
20. Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children.
Haque R; Ali IM; Sack RB; Farr BM; Ramakrishnan G; Petri WA
J Infect Dis; 2001 Jun; 183(12):1787-93. PubMed ID: 11372032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
